Professor Mats O. Karlsson Mats O. Karlsson is a Professor of Pharmacometrics at Uppsala University, Sweden. He received his PhD in pharmacokinetics in 1989 and has been a research fellow at University of Glasgow and University of California, San Francisco and a visiting professor at Georgetown University, Washington DC. He has received the Uppsala University Oscar Prize, the Giorgio Segré Prize from EUFEPS and an Honorary Fellowship Award from American Collage of Clinical Pharmacology. He is European Editor of Journal of Pharmacokinetics and Pharmacodynamics. His research interests focus on methodological aspects of non-linear mixed effects model building and applications of PKPD modeling to problems in drug development and routine drug therapy. He has published over 150 original research articles in this area.
Professor Lena Friberg Lena Friberg is a Professor of Pharmacometrics at Uppsala University, Sweden. Lena obtained her PhD from Uppsala University in 2003. After a postdoc at University of Queensland, Australia, she returned to Uppsala University in 2005. Her research is focused on development of PK and (mechanistic) PKPD-models for effects and adverse events of drugs with a focus on oncology and bacterial infections. She is deputy Editor-in-Chief of CPT: Pharmacometrics & Systems Pharmacology and in 2008 she received the Giorgio Segré prize for distinction in the field of PKPD. She has published over 90 articles in the area.
Associate Professor Andrew C. Hooker Andrew Hooker is an Associate Professor of Pharmacometrics at Uppsala University, Sweden. Andrew received a BS in Physics with a Mathematics Minor at the University of Colorado, USA and received a Masters and then a PhD in Bioengineering from the University of Washington, USA in 2003. He was a post-doctoral fellow at Uppsala University before joining the faculty in 2006. His research ranges between methodological and applied pharmacometrics, including: optimal experimental design, methodological problems associated with building and evaluating pharmacometric models and the development and use of PKPD models in a range of therapeutic areas and drug classes including cancer, addiction, PET and biologics. In addition, Andrew is involved in the development of a number of software programs including PopED, Xpose 4 and PsN. He has over 50 original research articles published in the field.
Professor Ulrika Simonsson Ulrika Simonsson is a Professor of Pharmacokinetics at Uppsala University, Sweden. Ulrika received her PhD from Uppsala University in 2000 and spent one year as a post-doc fellow at Pharsight, Mountain View, CA. She has a 2 years experience of working at AstraZeneca where she received an innovation award for implementation of model-based drug development as well as a reward as a talented young scientist. Her research involves development of PKPD models for several therapeutic areas such as anticoagulation, tuberculosis, HIV, malaria and pain.